Kim et al. demonstrated that RGE decreased CRC tumor cell invasion and migration as well as hypoxia-induced epithelial to mesenchymal transition by inhibiting the activation of the NF-κB and ERK1/2 signaling pathways [41]. The gene discussed is NFKB1; the disease is colorectal carcinoma.